140610 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Ensol Biosciences, Inc. manufactures and sells drugs. The firm develops BT·IT convergence technology (the core bioinformatics technology) such as in-silico genome analysis system, transcriptome analysis system, proteome analysis system and metabolome analysis system. It has been investing in developing bio-hydrogen energy, bio-environments, bio-foods and bio-cosmetics. The company was founded by Hae-Jin Kim on February 20, 2001 and is headquartered in Daejeon, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
140610 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company